Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heska Corp (NASDAQ:HSKA)

97.12
Delayed Data
As of Jun 26
 -0.38 / -0.39%
Today’s Change
35.18
Today|||52-Week Range
110.25
+35.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$693.8M

Company Description

Heska Corp. engages in the research, development and manufacture of veterinary products. The company operates through two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals & Products. The Core Companion Animal Health segment supplies blood testing instruments, digital imaging software, heartworm diagnostic tests and preventive products, allergy immunotherapy products, and allergy testing. The Other Vaccines, Pharmaceuticals and Products segment develops and distributes vaccines and pharmaceutical products. Its solutions include, dri-chem 4000, 7000, hematrue, element ht5, element i and solo step heartworm. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Contact Information

Heska Corp.
3760 Rocky Mountain Avenue
Loveland Colorado 80538
P:(970) 493-7272
Investor Relations:

Employees

Shareholders

Other institutional45.52%
Mutual fund holders36.55%
Individual stakeholders19.76%

Top Executives

Kevin S. WilsonPresident, Chief Executive Officer & Director
Jason A. NapolitanoSecretary, Chief Operating & Strategist Officer
John McMahonChief Financial Officer & Vice President
Nancy WisnewskiEVP-Diagnostic Operations & Product Development
Michael J. McGinleyPresident-Biologicals & Pharmaceuticals